Cancer Family
Meningothelial Cell Neoplasm
CI-CAN-00000263Explore in graph →
Non-malignant65 active trials2 evidence items
- NCIt
- C6971
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000263Explore in graph →
Clinical trials
185 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04648462 | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | recruiting | — | 1,500 | Maastricht Radiation OncologyOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT06684795 | FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT01117844 |
| Proton Radiation For Meningiomas and Hemangiopericytomas |
| completed |
| Phase 1 / Phase 2 |
| 53 |
| Abramson Cancer Center at Penn MedicineOTHER |
| 1 |
| Nov 7, 2024 |
| clinicaltrials |
| NCT06640582 | TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas(BAH2472) | recruiting | Phase 1 / Phase 2 | 85 | Essen BiotechOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT04501705 | Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults | recruiting | N/A | 29 | Beijing Sanbo Brain HospitalOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT03631953 | Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas(ALTREM) | unknown | Phase 1 | 25 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT03434262 | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors | completed | Phase 1 | 68 | St. Jude Children's Research HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT04079595 | Closed vs. Open Face Masks for Cranial Radiotherapy | completed | N/A | 60 | University of ZurichOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT05727605 | Neurocognition After Radiotherapy in CNS- and Skull-base Tumors(NARCiS) | recruiting | N/A | 120 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06278103 | Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M)(MethylRH-M) | unknown | — | 180 | Central Hospital, Nancy, FranceOTHER | 0 | Feb 26, 2024 | clinicaltrials |
| NCT01166321 | Carbon Ion Radiotherapy for Atypical Meningiomas(MARCIE) | unknown | N/A | 35 | University Hospital HeidelbergOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT05537675 | Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction(177Lumen) | completed | — | 20 | Central Hospital, Nancy, FranceOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT00019578 | Stereotactic Radiosurgery in Treating Patients With Brain Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04372095 | Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study(ANDROMEDE-F) | unknown | — | 2,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT04478877 | Establishment and Characterization of Meningioma Patient-derived Organoids | completed | — | 20 | Chinese University of Hong KongOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT03953131 | Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas | completed | Phase 1 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT03267836 | Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma | terminated | Phase 1 | 9 | Washington University School of MedicineOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT02333565 | Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas(CEVOREM) | completed | Phase 2 | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT04712214 | Use of Non-invasive Optical Analysis in Neurosurgery | unknown | N/A | 50 | Imperial College LondonOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05821790 | Role of the Tumor Microenvironment in Aggressive Meningiomas(MEME) | unknown | — | 40 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Apr 20, 2023 | clinicaltrials |
| NCT03273712 | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) | completed | Phase 2 | 39 | University of IowaOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT03071874 | Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas | active not recruiting | Phase 2 | 28 | Massachusetts General HospitalOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT05230381 | Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection | unknown | N/A | 228 | Beijing Tiantan HospitalOTHER | 1 | Aug 29, 2022 | clinicaltrials |
| NCT02978677 | Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas(PANAMA) | not yet recruiting | N/A | 90 | Technische Universität DresdenOTHER | 0 | Aug 3, 2022 | clinicaltrials |
| NCT02831257 | AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas | completed | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT02973256 | Oncological Care for Patients With Meningioma(ATYPICMENING) | unknown | — | 1,204 | University Hospital, MontpellierOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05028400 | Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery(LSCI-NSURG) | completed | N/A | 20 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT00972335 | Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma | terminated | Phase 2 | 18 | SCRI Development Innovations, LLCOTHER | 1 | Nov 10, 2021 | clinicaltrials |
| NCT05093751 | Automated Segmentation and Volumetry for Meningioma Using Deep Learning | completed | — | 600 | Seoul National University HospitalOTHER | 0 | Oct 26, 2021 | clinicaltrials |
| NCT04728568 | Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma | unknown | N/A | 15 | Beijing Tiantan HospitalOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT01967823 | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2021 | clinicaltrials |
| NCT02255461 | Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors | terminated | Phase 1 | 35 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Mar 2, 2021 | clinicaltrials |
| NCT03001349 | 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors | terminated | Early Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT04386642 | Tranexamic Acid Reduce Blood Loss in Meningioma Resection | unknown | Phase 4 | 44 | Chiang Mai UniversityOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT01125046 | Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas | completed | Phase 2 | 50 | Northwestern UniversityOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT04710485 | Sphenoorbital Meningioma Management. | unknown | — | 24 | Assiut UniversityOTHER | 0 | Jan 14, 2021 | clinicaltrials |
| NCT01024907 | Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas | completed | Phase 1 / Phase 2 | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03558516 | Magnesium and Intraoperative Blood Loss in Meningioma Surgery | completed | Phase 3 | 80 | Mahidol UniversityOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT01347307 | Stereotactic Body Radiotherapy for Spine Tumors | completed | N/A | 38 | Mercy ResearchOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT01880749 | Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas | completed | Early Phase 1 | 5 | NYU Langone HealthOTHER | 1 | May 13, 2020 | clinicaltrials |
| NCT03936426 | Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ | completed | Phase 1 / Phase 2 | 5 | Clarity Pharmaceuticals LtdINDUSTRY | 1 | Apr 20, 2020 | clinicaltrials |
| NCT03648034 | Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality | completed | N/A | 144 | RenJi HospitalOTHER | 1 | Apr 6, 2020 | clinicaltrials |
| NCT03015701 | S9005 Mifepristone in Meningioma | completed | Phase 3 | 193 | SWOG Cancer Research NetworkNETWORK | 0 | Dec 23, 2019 | clinicaltrials |
| NCT04109404 | Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin(MAP) | completed | — | 110 | University Hospital, BrestOTHER | 1 | Oct 11, 2019 | clinicaltrials |
| NCT01151670 | Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors | completed | Phase 1 | 18 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT00919750 | Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors | completed | — | 1,258 | Children's Oncology GroupNETWORK | 6 | Jul 16, 2018 | clinicaltrials |
| NCT01234805 | Yoga Therapy in Treating Patients With Malignant Brain Tumors | terminated | N/A | 9 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT00859040 | Monthly SOM230C for Recurrent or Progressive Meningioma | completed | Phase 2 | 34 | Patrick Y. Wen, MDOTHER | 1 | Oct 27, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Nov 26, 2024source: clinicaltrials